Regorafenib induces NOX5-mediated endoplasmic reticulum stress and potentiates the anti-tumor activity of cisplatin in non-small cell lung cancer cells-Reference-Cited by-同舟云学术

Regorafenib induces NOX5-mediated endoplasmic reticulum stress and potentiates the anti-tumor activity of cisplatin in non-small cell lung cancer cells

Published:2023-05 Issue: Volume:39 Page:100897
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Sui Hehuan,Xiao Sisi,Jiang Suping,Wu Siyuan,Lin Haizhen,Cheng Liyuan,Ye Lihua,Zhao Qi,Yu Yun,Tao Lu,Kong Feng-Ming,Huang Xiaoying,Cui Ri

Funder

National Natural Science Foundation of China

Natural Science Foundation of Zhejiang Province

Publisher

Elsevier BV

Subject

Cancer Research

Reference42 articles.

1. Lung cancer;Nasim;Med. Clin. North Am.,2019

2. Adjuvant and neoadjuvant immunotherapy in non-small cell lung cancer;Broderick;Thorac. Surg. Clin.,2020

3. Lung Cancer 2020: epidemiology, etiology, and prevention;Bade;Clin. Chest Med.,2020

4. The biology and management of non-small cell lung cancer;Herbst;Nature,2018

5. Cisplatin in the modern era: the backbone of first-line chemotherapy for non-small cell lung cancer;Fennell;Cancer Treat. Rev.,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical significance of endoplasmic reticulum stress related genes in non-small cell lung cancer and analysis of single nucleotide polymorphism for CAV1;Frontiers in Molecular Biosciences;2024-08-06

2. NADPH oxidase 5: Where are we now and which way to proceed?;Redox Biochemistry and Chemistry;2024-08

3. Promoting reactive oxygen species accumulation to overcome tyrosine kinase inhibitor resistance in cancer;Cancer Cell International;2024-07-09

4. Multikinase inhibitors modulate non-constitutive proteasome expression in colorectal cancer cells;Frontiers in Molecular Biosciences;2024-05-07

5. Effects of Natural Products through Inhibiting Endoplasmic Reticulum Stress on Attenuation of Idiopathic Pulmonary Fibrosis;Drug Design, Development and Therapy;2024-05